Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Nov 4;16(11):e0258499.
doi: 10.1371/journal.pone.0258499. eCollection 2021.

Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis

S R Gil-Quiñones  1 , I T Sepúlveda-Pachón  1 , G Sánchez Vanegas  2 , L D Gutierrez-Castañeda  3
Affiliations
Meta-Analysis

Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis

S R Gil-Quiñones et al. PLoS One. .

Abstract

Objectives: Genetic association studies on alopecia areata (AA) performed in various populations have shown heterogeneous results. The aim of the current review was to synthesize the results of said studies to estimate the impact of FAS, FASL, PTPN22, CTLA4 and IL2RA gene polymorphisms on AA susceptibility.

Design: A systematic literature search was conducted in the Medline, Web of Science, Scopus, EMBASE and LILACS databases. Studies published up to June 2020 were included. The results available in the grey literature including the Open Grey and Google Scholar databases were also used. The texts of potentially related studies were screened by individual reviewers. Evidence of publication bias was assessed using the Newcastle-Ottawa scale and the quality of evidence was assessed using the GRADE system. The quantitative synthesis was performed using the fixed effect model.

Results: Out of 1784 articles, we identified 18 relevant articles for the qualitative synthesis and 16 for the quantitative synthesis. In a study of rs2476601 polymorphism of PTPN22 gene, including 1292 cases and 1832 controls, a correlation was found with the risk of developing AA in the allelic model (OR1.49 [95% C:1.13-1.95]), the heterozygous codominant (OR1.44 [95% CI:1:19-1.76]) and dominant model (OR1.43 [95% CI:1.18-1.73]). No association was found between the presence of FASL, PTPN22, CTLA and IL2RA gene polymorphisms with AA susceptibility.

Conclusions: The results suggest that the T allele of the single nucleoid polymorphism (SNP) rs2476601 in PTPN22 gene is a risk factor for developing alopecia areata. However, more robust studies defining the ethnic background of the population of origin are required, so that the risk identified in the present study can be validated. Additionally, a greater number of studies is necessary to evaluate the role of the FAS, FASL, PTPN22, CTLA4 and IL2RA genetic variants, given the heterogenous results found in the literature.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study flow diagram.
Fig 2
Fig 2. Association between rs2476601 polymorphism of PTPN22 gene and the risk of alopecia areata.
Allelic model T vs C. Exposed group: patients with allele T; Unexposed group: patients with allele C.
Fig 3
Fig 3. Association between rs2476601 polymorphism of PTPN22 gene and risk of alopecia areata.
Codominant model (CT vs CC).
Fig 4
Fig 4. Association between rs2476601 polymorphism of PTPN22 gene and risk of alopecia areata.
Dominant model (CT+TT vs CC).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3: 17011. doi: 10.1038/nrdp.2017.11 - DOI - PMC - PubMed
    1. Guo H, Cheng Y, Shapiro J, McElwee K. The role of lymphocytes in the development and treatment of alopecia areata. Expert Review of Clinical Immunology. 2015;11: 1335–1351. doi: 10.1586/1744666X.2015.1085306 - DOI - PMC - PubMed
    1. Gilhar A, Etzioni A, Paus R. Alopecia Areata. N Engl J Med. 2012;366: 1515–25. doi: 10.1056/NEJMra1103442 - DOI - PubMed
    1. Moravvej H, Tabatabaei-Panah P-S, Abgoon R, Khaksar L, Sokhandan M, Tarshaei S, et al. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.: 15. - PubMed
    1. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, et al.. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466: 113–117. doi: 10.1038/nature09114 - DOI - PMC - PubMed

Publication types

MeSH terms